华纳药厂2025年净利2.41亿元，同比增长46.95%

Core Viewpoint - Warner Pharmaceutical (688799) reported a revenue of 1.516 billion yuan for the year 2025, reflecting a year-on-year growth of 7.26%, and a net profit attributable to shareholders of 241 million yuan, which represents a significant increase of 46.95% [1] Group 1 - The increase in revenue is attributed to growth in sales of formulation products, raw materials, intermediates, and technical service income [1] - The rise in net profit is primarily influenced by investment income [1]